Phase I clinical study of N-[(4-chlorophenyl)amino]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641).

Hainsworth JD, Hande KR, Satterlee WG, Kuttesch J, Johnson DH, Grindey G, Jackson LE, Greco FA
Cancer Res. 1989 49 (18): 5217-20

PMID: 2766290

MeSH Terms (10)

Antineoplastic Agents Drug Evaluation Female Humans Male Methemoglobinemia Middle Aged Neoplasms Sulfonylurea Compounds Time Factors

Connections (1)

This publication is referenced by other Labnodes entities:

Links